Original dataset composition (Raw from ADNI). by Muhammad Zubair (728141)

Subjects:

The ABAQUS model database of wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

Subjects:

Characteristics of the action protocols reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

Subjects:

Class-wise performance on the test set. by Muhammad Zubair (728141)

Subjects:

Comparison of the Classification performance of the proposed model calculated on the test set with state-of-the-art Approaches. by Muhammad Zubair (728141)

Subjects:

Details of Hyperparameters. by Muhammad Zubair (728141)

Subjects:

Comparative performance analysis of different architectures. by Muhammad Zubair (728141)

Subjects:

Anonymized data set: the anonymized data set necessary to replicate our study. by Zhao-Yang Meng (18389630)

Subjects:

Proposed Alzheimer’s disease classification pipeline using Multi-Scale EfficientNet with SVM. by Muhammad Zubair (728141)

Subjects:

The animation of tension changes after wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

Subjects:

Raw dataset. by Sakar Hasan Hamza (20978818)

Subjects:

Positive correlation between tourist arrivals per capita & level of prices. by Sakar Hasan Hamza (20978818)

Subjects:

Ablation Study Result. by Muhammad Zubair (728141)

Subjects:

Fig 1 - by Muhammad Naeem Sattar (19828497)

Subjects:

IL-33 supplementation fails to prevent trTreg reduction in established <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

A principled method to find OL enhancers for <i>Sox10.</i> by Hongjoo An (21703199)

Subjects:

Establishment of overexpressing <i>RP11-502I4.3</i> model in human retinal microvascular endothelial cells (HRMECs). by Lan Zeng (638254)

Subjects:

Transcriptome analysis of Δ<i>pbpp6</i> and WT <i>P. berghei</i> gametocytes. by Yonghui Feng (12227596)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Phosphoproteomic analysis of Δ<i>pbpp6</i> and WT <i>P. berghei</i> gametocytes. by Yonghui Feng (12227596)